Myocardial perfusion SPECT imaging in patients after percutaneous coronary intervention

Current Cardiology Reviews

Volumn 6, Issue 2, 2010, Pages 98-103

  Georgoulias, Panagiotis ^a   Valotassiou, Varvara ^a   Tsougos, Ioannis ^a   Demakopoulos, Nikolaos ^b  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b NIMTS HOSPITAL   (Greece)

Author keywords

Myocardial perfusion imaging (MPI); Percutaneous coronary intervention (PCI); Revascularization; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

CORONARY ARTERY DISEASE; EXERCISE ELECTROCARDIOGRAPHY; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RESTENOSIS; REVASCULARIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 77951648834     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310791162677     Document Type: Review

References (48)

1. Giedd KN, Bergmann SR. Myocardial perfusion imaging following percutaneous coronary intervention. The importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol 2004; 43: 328-336
2. Gruentzig AR, Senning A, Siegethaler WE. Nonoperative dilation of coronary artery stenosis: Perqutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-68 (Pubitemid 9229695)
3. Callif RM, Fortin DF, Frid DJ, et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991; 17: 2B-13B.
4. Gruentzig AR, King SB, Schlumpf M, Siegenthaler W. Long-term follow-up after perqutaneous transluminal coronary angioplasty: the early Zurich experience. N Engl J Med 1987; 316; 1127-1132
5. Goy JJ, Eeckhout E. Intracoronary stenting. Lancet 1998; 351: 1943-1949
6. Serruys P, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495
7. Kastrati A, Schömig A, Elezi S, et al. Prognostic value of the modified American College of Cardiology / American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999; 100: 1285-1290
8. De Jaegere PP, Eefting FD, Popma JJ, Seruys PW. Clinical trials on intracoronary stenting. Semin Interv Cardiol 1996; 1: 233-245
9. Dehmer GJ, Smith KJ. Drug-eluting coronary artery stents. Am Fam Physician 2009; 80:1245-1251
10. Gershlick AH, de Belder M, Chambers J GI, et al. Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group. Heart 2007; 93: 423-431
11. Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004; 31: 261-291
12. Adams GL, Ambati SR, Adams JM, Borges-Neto S. Role of nuclear imaging after coronary revascularization. J Nucl Cardiol 2006; 13: 163-169
13. Pfisterer ME, Zellweger MJ. In: Ell PJ, Gambhir SS, Eds. Nuclear medicine in clinical diagnosis and treatment. New York, Churchill Livingstone 2004; pp. 1149-1157
14. Violaris AG, Melkert R, Serruys PW. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. Circulation 1995; 91: 2140-2150
15. Zhang X, Liu X, He ZX, et al. Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after perqutaneous coronary intervention. Eur J Nucl Med Mol Imaging 2004; 31: 655-662
16. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: 77-81.
17. Suresh CG, Grant SC, Henderson RA, Bennett DH. Late symptom recurrence after successful coronary angioplasty: angiographic outcome. Int J Cardiol 1993; 42: 257-262
18. Ruygrok PN, Webster MW, de Valk V, et al. Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation 2001; 104: 2289-2294
19. Bavry AA, Bhatt DL. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet 2008 21; 371: 2134-2143
20. Mintz GS. Remodeling and Restenosis: Observations from Serial Intravascular Ultrasound Studies. Curr Interv Cardiol Rep 2000; 2: 316-325
21. Jaffe R, Haim SB, Karkabi B, et al. Myocardial perfusion abnormalities early (12-24 h) after coronary stenting or balloon angioplasty: Implications regarding pathophysiology and late clinical outcome. Cardiology 2002; 98: 60-66
22. Rodes-Cabau J, Candell-Riera J, Domingo E, et al. Frequency and clinical significance of myocardial ischemia detected early after coronary stent implantation. J Nucl Med 2001; 42:1768-1772
23. Bachmann R, Sechtem U, Voth E, Schroder J, Hopp HW, Schicha H. Dipyridamole scintigraphy and intravascular ultrasound after successful coronary intervention. J Nucl Med 1997; 38: 553-558
24. Kim DW, Park SA, Kim CG, Lee C, Oh SK, Jeong JW. Reversible defects on myocardial perfusion imaging early after coronary stent implantation: a predictor of late restenosis. Int J Cardiovasc Imaging 2008; 24: 503-510
25. Kurihara H, Nakamura S, Takehana K, et al. Scintigraphic prediction of left ventricular functional recovery early after primary coronary angioplasty using single-injection quantitative electrocardiographic gated SPECT. Nucl Med Commun 2005; 26: 505-511
26. Lauer MS. Role of stress testing and cardiac imaging in patients who have undergone previous coronary revascularization. Cardiol Rev 2000; 8: 158-165
27. Hecht HS, Shaw RE, Chin HL, et al. Silent ischemia after coronary angioplasty: Evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991; 17: 670-677
28. Garzon PP, Eisenberg MJ. Functional testing for the detection of restenosis after percutaneous transluminal coronary angioplasty: a meta-analysis. Can J Cardiol 2001; 17: 41-48
29. Georgoulias, P, Demakopoulos N, Kontos A, et al. Tc-99m tetrofosmin myocardial perfusion imaging before and six months after percutaneous transluminal coronary angioplasty. Clin Nucl Med 1998; 23: 678-682
30. Caner B, Oto A, Ovunc K, Kiratli P. Prediction of restenosis after successful percutaneous coronary angioplasty by dobutamine thallium-201 scintigraphy. Int J Cardiol 1998; 66: 175-181
31. Milavetz JJ, Miller JD, Hodge DO, Holmes DR, Gibbons RJ. Accuracy of single-photon emission computed tomography myocardial perfusion imaging in patients with stents in native coronary arteries. Am J Cardiol 1998; 82: 857-861
32. Lakkis NM, Mahmarian JJ, Verani MS. Exercise thallium-201 single photon emission computed tomography for the evaluation of coronary artery bypass graft patency. Am J Cardiol 1995; 76: 107-111
33. Rajagopal V, Lauer MS. In: Zaret BL, Beller GA Eds, Clinical nuclear cardiology: state of the art and future directions. Philadelphia, Mosby Inc. 2005; 339-347
34. Beygui F, Le Feuvre C, Maunoury C, et al. Detection of coronary restenosis by exercise electrocardiography thallium-201 perfusion imaging and coronary angiography in asymptomatic patients after percutaneous transluminal coronary angioplasty. Am J Cardiol 2000; 86: 35-40.
35. Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart E. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993; 22: 1446-1454
36. Acampa W, Petretta M, Florimonte L, Mattera A, Cuocolo A. Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients. Am J Cardiol 2003; 91: 259-263
37. Georgoulias P, Demakopoulos N, Tzavara C, et al. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention. Clin Nucl Med 2008; 33: 743-747
38. Georgoulias P, Tzavara C, Demakopoulos N, et al. Incremental prognostic value of 99mTc-tetrofosmin myocardial SPECT after percutaneous coronary intervention. Ann Nucl Med 2008; 22: 899-909.
39. Cottin Y, Rezaizadeh K, Touzery C, et al. Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting. Am Heart J 2001; 141: 999-1006.
40. Ho KT, Miller TD, Holmes DR, Hodge DO, Gibbons RJ. Long-term prognostic value of Duke treadmill score and exercise thallium-201 imaging performed one to three years after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999; 84: 1323-1327
41. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischaemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003; 42: 33-40.
42. Solodky A, Assali AR, Mats I, et al. Prognostic value of myocardial perfusion imaging in symptomatic and asymptomatic patients after percutaneous coronary intervention. Cardiology 2007; 107: 38-43.
43. Galassi AR, Grasso C, Azzarelli S, Ussia G, Moshiri S, Tamburino C. Usefulness of exercise myocardial scintigraphy in multivessel coronary disease after incomplete revascularization with coronary stenting. Am J Cardiol 2006; 97: 207-215
44. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Poldermans D. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography. J Nucl Cardiol 2003; 10: 615-622
45. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Endorsed by the American College of Emergency Physicians. J Am Coll Cardiol 2009; 53: 2201-2229
46. Anderson RD, Ohman EM, Holmes DR, et al. Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 1998; 32: 936-941
47. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001; 38: 659-665
48. L'Huillier I, Cottin Y, Touzery C, et al. Predictive value of myocardial tomoscintigraphy in asymptomatic diabetic patients after percutaneous coronary intervention. Int J Cardiol 2003; 90: 165-173